48 related articles for article (PubMed ID: 2831731)
1. Dimethyl amiloride, a Na+-H+ exchange inhibitor, and its cardioprotective effects in hemorrhagic shock in in vivo resuscitated rats.
Soliman M
J Physiol Sci; 2009 May; 59(3):175-80. PubMed ID: 19340541
[TBL] [Abstract][Full Text] [Related]
2. Ursodeoxycholic acid protects against intestinal barrier breakdown by promoting enterocyte migration via EGFR- and COX-2-dependent mechanisms.
Golden JM; Escobar OH; Nguyen MVL; Mallicote MU; Kavarian P; Frey MR; Gayer CP
Am J Physiol Gastrointest Liver Physiol; 2018 Aug; 315(2):G259-G271. PubMed ID: 29672156
[TBL] [Abstract][Full Text] [Related]
3. Active enterohepatic cycling is not required for the choleretic actions of 24-norUrsodeoxycholic acid in mice.
Truong JK; Li J; Li Q; Pachura K; Rao A; Gumber S; Fuchs CD; Feranchak AP; Karpen SJ; Trauner M; Dawson PA
JCI Insight; 2023 Mar; 8(6):. PubMed ID: 36787187
[TBL] [Abstract][Full Text] [Related]
4. Loss of luminal carbonic anhydrase XIV results in decreased biliary bicarbonate output, liver fibrosis, and cholangiocyte proliferation in mice.
Zhou Z; Qian J; Kini A; Riederer B; Römermann D; Gros G; Seidler U
Pflugers Arch; 2022 May; 474(5):529-539. PubMed ID: 35119514
[TBL] [Abstract][Full Text] [Related]
5. Oriental Cholangiohepatitis in a Caucasian male.
Suarez LSK; Simms LN; Deeb K; Scott CE
SAGE Open Med Case Rep; 2021; 9():2050313X211035573. PubMed ID: 34377484
[TBL] [Abstract][Full Text] [Related]
6. Irinotecan-induced neutropenia is reduced by oral alkalization drugs: analysis using retrospective chart reviews and the spontaneous reporting database.
Hamano H; Mitsui M; Zamami Y; Takechi K; Nimura T; Okada N; Fukushima K; Imanishi M; Chuma M; Horinouchi Y; Izawa-Ishizawa Y; Kirino Y; Nakamura T; Teraoka K; Ikeda Y; Fujino H; Yanagawa H; Tamaki T; Ishizawa K
Support Care Cancer; 2019 Mar; 27(3):849-856. PubMed ID: 30062585
[TBL] [Abstract][Full Text] [Related]
7. Ursodeoxycholic acid attenuates 5-fluorouracil-induced mucositis in a rat model.
Kim SH; Chun HJ; Choi HS; Kim ES; Keum B; Seo YS; Jeen YT; Lee HS; Um SH; Kim CD
Oncol Lett; 2018 Aug; 16(2):2585-2590. PubMed ID: 30008943
[TBL] [Abstract][Full Text] [Related]
8. Bile acids stimulate cholangiocyte fluid secretion by activation of transmembrane member 16A Cl
Li Q; Dutta A; Kresge C; Bugde A; Feranchak AP
Hepatology; 2018 Jul; 68(1):187-199. PubMed ID: 29360145
[TBL] [Abstract][Full Text] [Related]
9. Prevention of hepatocellular carcinoma: Focusing on antioxidant therapy.
Miyanishi K; Hoki T; Tanaka S; Kato J
World J Hepatol; 2015 Mar; 7(3):593-9. PubMed ID: 25848483
[TBL] [Abstract][Full Text] [Related]
10. Ursodeoxycholic acid ameliorates experimental ileitis counteracting intestinal barrier dysfunction and oxidative stress.
Bernardes-Silva CF; Damião AO; Sipahi AM; Laurindo FR; Iriya K; Lopasso FP; Buchpiguel CA; Lordello ML; Agostinho CL; Laudanna AA
Dig Dis Sci; 2004 Oct; 49(10):1569-74. PubMed ID: 15573906
[TBL] [Abstract][Full Text] [Related]
11. Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.
Nishigaki Y; Ohnishi H; Moriwaki H; Muto Y
Dig Dis Sci; 1996 Jul; 41(7):1487-93. PubMed ID: 8689929
[TBL] [Abstract][Full Text] [Related]
12. Metabolism of orally administered tauroursodeoxycholic acid in patients with primary biliary cirrhosis.
Setchell KD; Rodrigues CM; Podda M; Crosignani A
Gut; 1996 Mar; 38(3):439-46. PubMed ID: 8675100
[TBL] [Abstract][Full Text] [Related]
13. Quantitative assessment of canalicular bile formation in isolated hepatocyte couplets using microscopic optical planimetry.
Gautam A; Ng OC; Strazzabosco M; Boyer JL
J Clin Invest; 1989 Feb; 83(2):565-73. PubMed ID: 2913052
[TBL] [Abstract][Full Text] [Related]
14. Hepatocellular bile acid transport and ursodeoxycholic acid hypercholeresis.
Scharschmidt BF; Lake JR
Dig Dis Sci; 1989 Dec; 34(12 Suppl):5S-15S. PubMed ID: 2689116
[TBL] [Abstract][Full Text] [Related]
15. Rat hepatocytes exhibit basolateral Na+/HCO3- cotransport.
Renner EL; Lake JR; Scharschmidt BF; Zimmerli B; Meier PJ
J Clin Invest; 1989 Apr; 83(4):1225-35. PubMed ID: 2539394
[TBL] [Abstract][Full Text] [Related]
16. Ursodeoxycholic acid choleresis: relationship to biliary HCO-3 and effects of Na+-H+ exchange inhibitors.
Renner EL; Lake JR; Cragoe EJ; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1988 Feb; 254(2 Pt 1):G232-41. PubMed ID: 2831731
[TBL] [Abstract][Full Text] [Related]
17. Effects of Na+ replacement and amiloride on ursodeoxycholic acid-stimulated choleresis and biliary bicarbonate secretion.
Lake JR; Van Dyke RW; Scharschmidt BF
Am J Physiol; 1987 Feb; 252(2 Pt 1):G163-9. PubMed ID: 3826345
[TBL] [Abstract][Full Text] [Related]
18. Ursodeoxycholate-induced changes in hepatic Na+-H+ exchange and biliary HCO3- excretion.
Anwer MS; Hondalus MK; Atkinson JM
Am J Physiol; 1989 Sep; 257(3 Pt 1):G371-9. PubMed ID: 2551181
[TBL] [Abstract][Full Text] [Related]
19. The effect of amiloride on biliary HCO3- secretion in the anaesthetized pig.
Grotmol T; Buanes T; Raeder MG
Acta Physiol Scand; 1987 Jul; 130(3):447-55. PubMed ID: 3630723
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
